This guideline would obviously exclude Candida and
Aspergillus diseases. Practically all invasive fungal diseases (IFD),
including invasive candidiasis and aspergillosis, appear to be
rare and emerging infections by definition. Although many IFD
are still numerically rare, physicians treating immunosuppressed
patients are increasingly confronted with a wide
variety of fungal pathogens.